Radiotherapy & Oncology
Volume 93, Issue 1 , Pages 32-36 , October 2009

Functional image-based radiotherapy planning for non-small cell lung cancer: A simulation study

  • Emma L. Bates

      Affiliations

    • Department of Clinical Oncology, Weston Park Hospital, UK
    • Corresponding Author InformationCorresponding author. Address: Department of Clinical Oncology, Weston Park Hospital, Sheffield Teaching Hospitals NHS Trust, Registrars’ Room, Broomcross Building, Sheffield S10 2SJ, UK.
  • ,
  • Christopher M. Bragg

      Affiliations

    • Department of Radiotherapy Physics, Weston Park Hospital, UK
  • ,
  • Jim M. Wild

      Affiliations

    • Academic Unit of Radiology, University of Sheffield, UK
  • ,
  • Matthew Q.F. Hatton

      Affiliations

    • Department of Clinical Oncology, Weston Park Hospital, UK
    • Academic Unit of Clinical Oncology, University of Sheffield, UK
  • ,
  • Rob H. Ireland

      Affiliations

    • Academic Unit of Radiology, University of Sheffield, UK
    • Academic Unit of Clinical Oncology, University of Sheffield, UK

Received 21 January 2009 ,Revised 19 May 2009 ,Accepted 24 May 2009.

References 

  1. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit or declining surgery (medically inoperable). Cochrane Database Syst Rev. 2001;2:CD002935
  2. Jeremic B, Milicic B, Dagovic A, Acimovic L, Milisavljevic S. Pretreatment prognostic factors in patients with early stage (I/II) non-small-cell lung cancer treated with hyperfractionated radiation therapy alone. Int J Radiat Oncol Biol Phys. 2006;65:1112–1119
  3. Byhardt RW, Scott CB, Sause WT, et al. Response, toxicity, failure patterns and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 1998;42:469–478
  4. Sause W, Kolesar P, Taylor S, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Chest. 2000;117:358–364
  5. Martel MK, Ten Haken RK, Hazuka MB, et al. Estimation of tumour control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung cancer. 1999;24:31–37
  6. Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:324–333
  7. Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2003;58:1258–1267
  8. Liu HH, Wang X, Dong L, et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1268–1279
  9. Marks LB, Spencer DP, Sherhouse GW, et al. The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose–volume histogram. Int J Radiat Oncol Biol Phys. 1995;33:65–75
  10. Seppenwoolde Y, Engelsman M, De Jaeger K, et al. Optimizing radiation treatment plans for lung cancer using lung perfusion information. Radiother Oncol. 2002;63:165–177
  11. Lavrenkov K, Christian JA, Partridge M, et al. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer. Radiother Oncol. 2007;83:156–162
  12. Shioyama Y, Jang SY, Liu HH, et al. Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;68:1349–1358
  13. Mcguire SM, Zhou S, Marks LB, Dewhurst M, Yin F-F, Das SK. A methodology for using SPECT to reduce intensity-modulated radiation therapy (IMRT) dose to functioning lung. Int J Radiat Oncol Biol Phys. 2006;66:1543–1552
  14. Yaremko BP, Guerrero TM, Noyola-Martinez J, et al. Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance. Int J Radiat Oncol Biol Phys. 2007;68:562–571
  15. Stavngaard T, Sogaard LV, Mortensen J, et al. Hyperpolarized 3He MRI and 81mKr SPECT in chronic obstructive pulmonary disease. Eur J Nucl Med Mol Imaging. 2005;32:448–457
  16. Van Beek EJ, Wild JM. Hyperpolarized 3-helium magnetic resonance imaging to probe lung function. Proc Am Thorac Soc. 2005;2:528–532
  17. Christian JA, Partridge M, Niotsikou E, et al. The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer. Radiother Oncol. 2005;77:271–277
  18. Ireland RH, Bragg C, McJury M, et al. Feasibility of image registration and intensity-modulated radiotherapy planning with hyperpolarized helium-3 magnetic resonance imaging for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;68:273–281
  19. Lavrenkov K, Singh S, Christian JA, et al. Effective avoidance of a functional SPECT-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning study. Radiother Oncol. 2009;91:349–352
  20. Ireland RH, Woodhouse N, Hoggard N, et al. An image acquisition and registration strategy for the fusion of hyperpolarized helium-3 MRI and X-ray CT images of the lung. Phys Med Biol. 2008;53:6055–6063
  21. Bragg CM, Wingate K, Conway J. Clinical implications of the anisotropic analytical algorithm for IMRT treatment planning and verification. Radiother Oncol. 2008;86:276–284
  22. Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet. 1997;350:161–165

PII: S0167-8140(09)00268-0

doi: 10.1016/j.radonc.2009.05.018

Radiotherapy & Oncology
Volume 93, Issue 1 , Pages 32-36 , October 2009